Deal watch: Bristol-Myers Squibb invests in cancer antibody that targets the innate immune system.Published in:2011Publication type:journal article
Business digest.Published in:Chemistry & Industry, 2011, n. 10, p. 13, doi. 10.1002/cind.7523_4.xBy:Whitfield, MarkPublication type:Article
First in class stimulates natural killer cells.Published in:Nature Biotechnology, 2006, v. 24, n. 6, p. 597, doi. 10.1038/nbt0606-597By:Sheridan, CormacPublication type:Article